View of Safety of Dapagliflozinin Reducing Cardiac Events and Deaths among NYHA Class II and III Cardiac Failure Patients.

Return to Article Details Safety of Dapagliflozinin Reducing Cardiac Events and Deaths among NYHA Class II and III Cardiac Failure Patients. Download Download PDF